300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Franchise
Financial Services
Non Profit
Android
Internet
Mobile Advertising
Proptech
Impact
Sustainability
Enterprise
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Japan
Oman
Puerto Rico
Poland
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Ireland
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Meyer Ventures, VC Fund

Meyer Ventures

VC Fund

New York, United States

Meyer Ventures is a merchant bank focused on strategic growth investments & the management of a "FAMILY OFFICE" portfolio

Total investments:
15
Last investment:
Lead investor:
0%

Last updated:

Industries Meyer Ventures invests in

MedicalHealth CareSoftwareBiotechnologySaaS

Stages Meyer Ventures invests in

SeedSeries ASeries BSeries ESecondary Market

Countries Meyer Ventures invests in

United States

Contacts

NameEmailPhoneSocials
Anthony Meyer Anthony Meyer

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 5 (33%)
  • Health Care 5 (33%)
  • Software 3 (20%)
  • Biotechnology 3 (20%)
  • SaaS 2 (13%)
See all 39 industries →

Stage

  • Seed 5 (33%)
  • Series A 5 (33%)
  • Series B 2 (13%)
  • Series E 1 (7%)
  • Secondary Market 1 (7%)
See all 6 stages →

Team

NameTitleInvestmentsLinksEmail
Anthony Meyer
Anthony Meyer Chairman and Chief Executive Officer
Chairman and Chief Executive Officer Total investments: 0
Find email

Investments

CompanyDescriptionRoundLinks
Volastra Therapeutics Volastra Therapeutics
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers by exploiting unique insights into chromosomal instability $60M / Series A / Mar 07, 2023
98point6 98point6
98point6 is a digital primary care service that delivers personalized consultation, diagnosis, and treatment to patients. The company combines deep technology with the expertise of board-certified physicians to provide text-based primary care anytime, anywhere. The company meets consumers where they are by offering private, text-based diagnosis andtreatment via a mobile app. The company was founded in 2015 and is headquartered in Seattle, Washington. $118M / Series E / Oct 15, 2020
Noteworth Noteworth
Noteworth is connecting healthcare organizations to patient-generated health data and provides software and services that allow clinicians and healthcare organizations to have an unprecedented level of health data clarity for patients outside the clinic.The startup company works with primary care doctors, pediatricians, and specialists to improvepatient engagement on an ongoing basis, whether it be through collecting information on vitals, providing education on diagnosis, and avenues to talk to a doctor via telemedicine or chat. Its HIPAA-compliant, interoperable solution integrates with 400+ FDA-approved clinical devices and delivers patient-generated data directly into an existing electronic medical record (EMR) in actionable, clinically-relevant Noteworth Reports. They position their partners to target costly readmissions, reduce utilization, boost patient satisfaction, and increase the overall quality of care.The Hoboken, New Jersey-based company was founded by Bryan Bonnet, Justin Williams, and Nishant Panchal in 2015. $5M / Seed / Jul 14, 2020
ReferWell ReferWell
ReferWell connects providers into Virtually Integrated Networks that optimize transitions of care. We help you drive the patient journey through the last mile with complete visibility into all interactions—so providers and payers can close the loop efficiently.With our system, you’ll direct patients toward the highest-quality providers, increasepatient compliance, reduce leakage and close more care gaps. Clients raise revenue by increasing keepage, improving STAR ratings and getting more members’ HCC coding updated. Our comprehensive suite of services connects to all your EMRs for streamlined referrals, point-of-care appointment scheduling and care team support, including provider directory management, eConsult and telehealth capabilities. Venture - Series Unknown / Mar 25, 2020
Next Big Idea Club Next Big Idea Club
Next Big Idea Club is a subscription book club. Their goal is to make sure that everyone has access to these transformative ideas, and to nurture a community to discuss and build upon those ideas—both with each other and directly with the authors themselves. Seed / Jan 22, 2020
AIStorm AIStorm
AIStorm is an AI startup that develops chipsets that can process data directly from devices. AIS technology is analog and mixed-signal technology. The sensor itself can deal with events, make decisions, and can perform complex analysis. The company was founded in 2011 and is headquartered in San Jose, California. $13.2M / Series A / Feb 11, 2019
Slack Slack
Slack is a cloud-based communication and collaboration platform for teams. It allows users to exchange messages, share files, and integrate with various business tools and services. Slack is commonly used across various industries, from tech startups to large enterprises. Secondary Market / Jan 28, 2019
DailyPay DailyPay
DailyPay offers a platform that allows employees to access their earned wages before their scheduled payday. The service integrates with employer payroll systems and provides tools for financial wellness. DailyPay aims to improve employee retention and engagement through flexible pay access. Seed / Oct 31, 2015
1DocWay 1DocWay
1DocWay is an online doctor's office. Rural, elderly, disabled and busy patients can schedule appointments online and see their doctor through our secure videochat platform. As a result, physicians increase scheduling flexibility and revenue opportunities by expanding their patient base, increasing reimbursement rates and replacing phone calls(not reimbursed) $1.7M / Seed / Jul 21, 2015
PierianDx PierianDx
PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases. PierianDx’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory, and shared knowledgebase are used by healthsystems, cancer centers and commercial laboratories worldwide driving the most integrated approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx has rapidly become the trusted source of ‘wisdom’ in every advanced genomic report. $3.9M / Series A / Jun 16, 2015
See all 15 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Franchise
Financial Services
Non Profit
Android
Internet
Mobile Advertising
Proptech
Impact
Sustainability
Enterprise
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Japan
Oman
Puerto Rico
Poland
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Ireland
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Meyer Ventures invest in?

Meyer Ventures invests primarily in Medical, Health Care and Software startups, most often at Seed and Series A stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Meyer Ventures?

Public channels for Meyer Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Meyer Ventures?

The team at Meyer Ventures includes Anthony Meyer (Chairman and Chief Executive Officer). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Meyer Ventures Meyer Ventures Find emails